NIOX Group Plc (AIM:NIOX)

Market Cap	276.63M +12.0%
Revenue (ttm)	48.70M +24.9%
Net Income	7.00M -40.2%
EPS	0.02 -36.7%
Shares Out	420.41M
PE Ratio	40.12
Forward PE	17.70
Dividend	0.02 (2.36%)
Ex-Dividend Date	May 21, 2026

Volume	332,080
Average Volume	840,715
Open	65.00
Previous Close	65.80
Day's Range	64.94 - 65.80
52-Week Range	53.84 - 77.60
Beta	-0.04
RSI	59.77
Earnings Date	Sep 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Pl...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2006
• Employees: 97
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.